BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10775782)

  • 1. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates.
    Stittelaar KJ; Vos HW; van Amerongen G; Kersten GF; Osterhaus AD; de Swart RL
    Vaccine; 2002 Dec; 21(3-4):155-7. PubMed ID: 12450688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
    Galletti R; Beauverger P; Wild TF
    Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis.
    da Fonseca DP; Frerichs J; Singh M; Snippe H; Verheul AF
    Vaccine; 2000 Aug; 19(1):122-31. PubMed ID: 10924794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
    Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
    Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells.
    Lipford GB; Wagner H; Heeg K
    Vaccine; 1994 Jan; 12(1):73-80. PubMed ID: 8303944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.
    Varsanyi TM; Morein B; Löve A; Norrby E
    J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
    Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
    Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
    Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.
    Jaye A; Magnusen AF; Sadiq AD; Corrah T; Whittle HC
    J Clin Invest; 1998 Dec; 102(11):1969-77. PubMed ID: 9835622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal adenovirus-vectored vaccine for measles.
    Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
    Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
    Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
    Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.